These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4394123)

  • 1. [Effect of a new beta-receptor blocking substance on human hemodynamics and metabolism].
    Niessner H; Lujf A; Moser K
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):277-81. PubMed ID: 4394123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies of the modification of myocardial metabolism with oxyfedrin].
    Niessner H; Lujf A; Moser K
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(2):163-74. PubMed ID: 5357616
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of oxyfedrin on hemodynamics and myocardial and hepatic metabolism in intact dogs after beta-adrenergic blockade].
    Niessner H; Raberger G; Lujf A; Moser K
    Res Exp Med (Berl); 1972; 158(4):288-97. PubMed ID: 5085437
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
    Reale A; Motolese M; Imhof P
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of ajmaline on ECG, hemodynamics and metabolism in man].
    Benda L; Lujf A; Moser K
    Wien Z Inn Med; 1966 Oct; 47(10):421-6. PubMed ID: 6005176
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of intravenously administered cortisol--with and without the addition of insulin or pretreatment with propranolol--on various parameters of fat and carbohydrate metabolism in blood plasma of human beings.
    Mischke WJ; Ebers S; Boisch KH; Tamm J
    Acta Endocrinol Suppl (Copenh); 1974; 186():1-45. PubMed ID: 4522424
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of prostaglandin E1 upon the general and coronary haemodynamics and metabolism of the intact dog.
    Maxwell GM
    Br J Pharmacol Chemother; 1967 Sep; 31(1):162-8. PubMed ID: 6055250
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid and carbohydrate metabolites in the blood of normal and obese subjects following intravenous administration of insulin, with special attention to the counterregulatory phases].
    Schmidt H; von Rotteck G; Voigt KD
    Endokrinologie; 1970; 57(1):1-9. PubMed ID: 4923989
    [No Abstract]   [Full Text] [Related]  

  • 9. [Central hemodynamics of the hyperkinetic syndrome under blockade with beta receptors].
    Juchems R; Wertz U
    Munch Med Wochenschr; 1969 Dec; 111(49):2567-71. PubMed ID: 4392881
    [No Abstract]   [Full Text] [Related]  

  • 10. General and coronary haemodynamic effects of 1-(O-allyloxphenoxy)-3-isopropylamino-2-propanol hydrochloride.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1968 May; 173(1):226-31. PubMed ID: 5657822
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
    Wolf P; Feller K; Femmer K
    Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic effect of a beta-receptor blocking agent (LB-46) on hemodynamics].
    Köhler M
    Z Kreislaufforsch; 1970 Aug; 59(8):708-19. PubMed ID: 5513291
    [No Abstract]   [Full Text] [Related]  

  • 13. Some haemodynamic effects of LB 46 (Visken).
    Smyth AJ; Watson O; Peel JS; Turner AS
    N Z Med J; 1970 Oct; 72(461):246-7. PubMed ID: 4395124
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in regional hemodynamics in response to blocking of the adrenergic beta receptors].
    Granata L; Caraffa Braga E; Cevese A; Data PG
    Boll Soc Ital Biol Sper; 1970 Feb; 46(4):170-3. PubMed ID: 4396928
    [No Abstract]   [Full Text] [Related]  

  • 15. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO; Fiehring H; Oltmanns G; Femmer K
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular, metabolic, and hormonal responses to noradrenaline in diabetic patients with autonomic neuropathy.
    Dejgaard A; Andersen P; Hvidberg A; Hilsted J
    Diabet Med; 1996 Nov; 13(11):983-9. PubMed ID: 8946158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical contribution to the knowledge of the relations between cyclic 3',5' AMP and catecholamines in cardiovascular function. (Study with adrenergic antagonists)].
    Starcich R; Barbaresi F; Volta G; Manfredi M
    Minerva Cardioangiol; 1967 Dec; 15(12):844-53. PubMed ID: 5610486
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of immediate haemodynamic effects of three beta-adrenergic blocking agents.
    Rivier JL; Nissiotis E; Jaeger M
    Postgrad Med J; 1970 Nov; ():Suppl:44-9. PubMed ID: 4395457
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the combined effect of alpha-blocking and beta-blocking drugs on tolerance to exertion in patients with acute coronary insufficiency].
    Pavarani A; Volta G; Barbaresi F; Starcich R
    Folia Cardiol; 1969; 28(1):37-41. PubMed ID: 4391632
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological aspects of oxprenolol.
    Brunner H; Hedwall PR; Maier R; Meier M
    Postgrad Med J; 1970 Nov; ():Suppl:5-14. PubMed ID: 4395460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.